Hepion Pharmaceuticals Inc
NASDAQ:HEPA

Watchlist Manager
Hepion Pharmaceuticals Inc Logo
Hepion Pharmaceuticals Inc
NASDAQ:HEPA
Watchlist
Price: 0.135 USD -57.55% Market Closed
Market Cap: 987.7k USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of HEPA.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HEPA Intrinsic Value
Not Available
Base Case Scenario
Compare HEPA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HEPA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hepion Pharmaceuticals Inc

Current Assets 1.6m
Cash & Short-Term Investments 406.4k
Other Current Assets 1.2m
Current Liabilities 3.1m
Accounts Payable 220.2k
Accrued Liabilities 23.7k
Short-Term Debt 2.9m
Non-Current Liabilities 333.2k
Other Non-Current Liabilities 333.2k
Efficiency

Free Cash Flow Analysis
Hepion Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hepion Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-19.3m USD
Operating Income
-19.3m USD
Other Expenses
6.2m USD
Net Income
-13.2m USD
Fundamental Scores

HEPA Profitability Score
Profitability Due Diligence

Hepion Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Hepion Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

HEPA Solvency Score
Solvency Due Diligence

Hepion Pharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
34/100
Solvency
Score

Hepion Pharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HEPA Price Targets Summary
Hepion Pharmaceuticals Inc

There are no price targets for HEPA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Hepion Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HEPA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HEPA Insider Trading
Buy and sell transactions by insiders